Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Necchi

Showing results (51-60 of 495) with videos related to

Pageof 50
Sort By:
Seminars in Oncology|May 12, 2019
Primary mediastinal germ cell tumorsGiovanni Rosti, Simona Secondino, Andrea Necchi, et al.
Urologic Oncology|November 3, 2009
Penile cancerRoberto Salvioni, Andrea Necchi, Luigi Piva, et al.
Current Opinion in Urology|October 14, 2017
Immunotherapy for metastatic urothelial carcinoma: status quo and the futureAndrea Necchi, Michael Rink, Patrizia Giannatempo, et al.
The Lancet. Oncology|February 1, 2023
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?Marco Bandini, Alessandro Nini, Alberto Briganti, et al.
International Journal of Surgical Pathology|December 8, 2010
Teratoma with somatic-type malignant components in germ cell tumors of the testis: a clinicopathologic analysis of 40 cases with outcome correlationMaurizio Colecchia, Andrea Necchi, Biagio Paolini, et al.
Investigational New Drugs|February 4, 2017
Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertibAndrea Necchi, Giulia Pintarelli, Daniele Raggi, et al.
The Lancet. Oncology|July 3, 2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitorsAlessandro Larcher, Umberto Capitanio, Andrea Necchi, et al.
European Urology|May 7, 2019
Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
The Journal of Urology|November 5, 2019
Re: Ten-Year Oncologic Outcomes following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy ConsortiumFrancesco Montorsi, Marco Moschini, Andrea Gallina, et al.
European Urology|July 14, 2023
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted AnalysisAntonio Cigliola, Chiara Mercinelli, Damiano Patanè, et al.
Pageof 50

Showing results (51-60 of 495) with videos related to

Sort By:
Pageof 50
Seminars in Oncology|May 12, 2019
Primary mediastinal germ cell tumorsGiovanni Rosti, Simona Secondino, Andrea Necchi, et al.
Urologic Oncology|November 3, 2009
Penile cancerRoberto Salvioni, Andrea Necchi, Luigi Piva, et al.
Current Opinion in Urology|October 14, 2017
Immunotherapy for metastatic urothelial carcinoma: status quo and the futureAndrea Necchi, Michael Rink, Patrizia Giannatempo, et al.
The Lancet. Oncology|February 1, 2023
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?Marco Bandini, Alessandro Nini, Alberto Briganti, et al.
International Journal of Surgical Pathology|December 8, 2010
Teratoma with somatic-type malignant components in germ cell tumors of the testis: a clinicopathologic analysis of 40 cases with outcome correlationMaurizio Colecchia, Andrea Necchi, Biagio Paolini, et al.
Investigational New Drugs|February 4, 2017
Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertibAndrea Necchi, Giulia Pintarelli, Daniele Raggi, et al.
The Lancet. Oncology|July 3, 2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitorsAlessandro Larcher, Umberto Capitanio, Andrea Necchi, et al.
European Urology|May 7, 2019
Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
The Journal of Urology|November 5, 2019
Re: Ten-Year Oncologic Outcomes following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy ConsortiumFrancesco Montorsi, Marco Moschini, Andrea Gallina, et al.
European Urology|July 14, 2023
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted AnalysisAntonio Cigliola, Chiara Mercinelli, Damiano Patanè, et al.
Pageof 50